Please login to the form below
Digital intelligence blog
Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools
by Dominic Tyer
J&J collaborates on consumer health device accelerator
Partners with Shenzhen-based investor firm HAX
Johnson & Johnson is working with Shenzhen-based investor firm HAX on an accelerator programme for novel consumer health devices.
The firm's Johnson & Johnson Innovation arm will work with HAX on supporting start-ups that are developing technologies in areas such as skin care, baby care and wound care.
The world's largest hardware accelerator with bases in Silicon Valley and south east China, HAX has a specific health track within its Shenzhen hardware accelerator.
Companies that have successfully applied to its spring 2017 call for entries and are then co-selected by HAX and J&J will receive mentorship in business development and commercialization from Johnson & Johnson Innovation executives.
They will also, HAX said, learn how to align their products with Johnson & Johnson's consumer health care portfolio.
Featured jobs
-
Principal Medical Writer
-
Great salary and benefits
- Scientific Director, Medical Communications
-
£60 – 70, 000 benefits
- Scientific Team Leader, Medical Education
-
£55, 000 – £70, 000 benefits
-
Account Director at PAREXEL MedCom
-
Competitive Salary
- Digital Account Director – Healthcare Communications
-
£50 – 60, 000 benefits
-
Medical Editor
-
Great salary and benefits
- Director of Scientific and Editorial Services
-
Great salary and benefits - Circa 100K
- Account Director, Healthcare Communications
-
£50, 000 - £60, 000
-
Editorial Director - BioScience
-
Competitive Salary
-
Account Director
-
Salary TBC
Subscribe to our email news alerts
- Roche and J&J picked for ‘revolutionary’ digital health pilot
- J&J files would-be prostate cancer blockbuster in US
- Pfizer could raise ‘up to $15bn’ from consumer unit sale
- Xarelto no better than aspirin in secondary stroke study
- Lilly strengthens team with in-house promotions
- NICE backs Pfizer’s Xeljanz for RA
PMHub
inVentiv Health Communications
inVentiv Health Communications brings together best-in-class agencies across advertising, digital, public relations, medical communications, research, market access and clinical trial...
Latest intelligence
- So how do you really engage with patients?
- The most valuable insights from patient engagement are the most unexpected ones. Simple things, which may seem unimportant to you, may be the key to making patients’ lives easier and...
- Avoiding data pitfalls in clinical research
- Genomics sequencing and sensors will present new challenges...
- Building a bright future
- Mylan takes a bold approach as it doubles its pipeline through R&D and acquisitions...
Quick links
Infographics
